WELLS FARGO & COMPANY/MN - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40,393
-57.6%
37,400
-49.4%
0.00%
Q2 2023$95,341
+105.6%
73,908
+110.4%
0.00%
Q1 2023$46,369
+6477.2%
35,128
+7374.0%
0.00%
Q4 2022$705
-85.9%
470
-87.0%
0.00%
Q3 2022$5,000
-73.7%
3,627
-78.0%
0.00%
Q2 2022$19,000
-96.9%
16,506
-92.0%
0.00%
Q1 2022$618,000
-17.6%
206,948
-26.9%
0.00%
Q4 2021$750,000
-2.2%
283,190
+34.2%
0.00%
Q3 2021$767,000
-86.7%
210,986
-84.1%
0.00%
-100.0%
Q2 2021$5,768,000
+136.3%
1,329,124
+86.3%
0.00%0.0%
Q1 2021$2,441,000
+68.7%
713,411
+72.5%
0.00%
Q4 2020$1,447,000
+9.0%
413,528
-25.2%
0.00%
Q3 2020$1,328,000
-37.5%
552,907
-52.4%
0.00%
-100.0%
Q2 2020$2,126,000
+113.2%
1,161,403
+81.7%
0.00%
Q1 2020$997,000
+42.8%
639,267
+96.2%
0.00%
Q4 2019$698,000
+2.9%
325,804
-10.2%
0.00%
Q3 2019$678,000
-29.6%
362,796
-1.6%
0.00%
Q2 2019$963,000
+33.8%
368,685
+31.5%
0.00%
Q1 2019$720,000
+239.6%
280,374
+203.9%
0.00%
Q4 2018$212,000
-24.0%
92,268
+6.2%
0.00%
Q3 2018$279,000
+13.4%
86,888
+0.1%
0.00%
Q2 2018$246,000
-21.9%
86,843
-2.4%
0.00%
Q1 2018$315,000
-7.6%
89,008
+1.2%
0.00%
Q4 2017$341,000
-67.6%
87,939
-78.8%
0.00%
Q3 2017$1,053,000
+101.7%
414,745
+116.9%
0.00%
Q2 2017$522,000
+40.7%
191,217
+70.6%
0.00%
Q1 2017$371,000
+134.8%
112,103
+68.6%
0.00%
Q4 2016$158,000
+25.4%
66,503
+94.5%
0.00%
Q3 2016$126,000
+133.3%
34,195
+40.7%
0.00%
Q2 2016$54,000
-16.9%
24,295
-22.0%
0.00%
Q1 2016$65,000
-13.3%
31,158
+26.2%
0.00%
Q4 2015$75,000
-1.3%
24,692
-19.2%
0.00%
Q3 2015$76,000
-31.5%
30,543
-11.7%
0.00%
Q2 2015$111,000
+38.8%
34,583
+55.2%
0.00%
Q1 2015$80,000
+700.0%
22,276
+401.5%
0.00%
Q4 2014$10,000
+11.1%
4,442
+0.7%
0.00%
Q3 2014$9,000
-70.0%
4,410
-44.7%
0.00%
Q2 2014$30,000
+650.0%
7,974
+712.0%
0.00%
Q1 2014$4,000
+33.3%
9820.0%0.00%
Q4 2013$3,000
-50.0%
982
-38.8%
0.00%
Q3 2013$6,000
+20.0%
1,6040.0%0.00%
Q2 2013$5,0001,6040.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders